Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets

Front Oncol. 2020 Feb 21:10:195. doi: 10.3389/fonc.2020.00195. eCollection 2020.

Authors

Cinzia Lanzi¹, Edwin Alexander Yates², Giuliana Cassinelli¹

Affiliations

¹ Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.

No abstract available

Keywords: cancer therapy; glypican; heparan sulfate proteoglycan; heparanase; sulfotransferase.

Publication types

Editorial